BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34706876)

  • 21. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.
    Multinu F; Casarin J; Cappuccio S; Keeney GL; Glaser GE; Cliby WA; Weaver AL; McGree ME; Angioni S; Faa G; Leitao MM; Abu-Rustum NR; Mariani A
    Gynecol Oncol; 2019 Jul; 154(1):60-64. PubMed ID: 31126637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
    Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Toprak S; Sahin EA; Sahin H; Tohma YA; Yilmaz E; Meydanli MM
    Int J Gynaecol Obstet; 2021 Apr; 153(1):51-55. PubMed ID: 33118165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
    Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
    Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
    Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
    J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer.
    Dinoi G; Garzon S; Weaver A; McGree M; Glaser G; Langstraat C; Kumar A; Weroha J; Garda AE; Shahi M; Palmieri E; Scambia G; Fanfani F; Mariani A
    Int J Gynecol Cancer; 2024 May; ():. PubMed ID: 38821549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
    Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
    Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical staging of low-risk Stage IA endometrioid endometrial cancers.
    Erdemoglu E; Yalcin Y; Bozkurt KK; Erdemoglu E
    Eur J Gynaecol Oncol; 2017; 38(1):80-84. PubMed ID: 29767870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
    Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
    Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.